4.8 Article

Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan

Journal

CELL
Volume 166, Issue 3, Pages 624-636

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2016.05.076

Keywords

-

Funding

  1. NIH [GM085796, T32AI089553, AI067995, AI062629]
  2. Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center

Ask authors/readers for more resources

Degradation of Gram-positive bacterial cell wall peptidoglycan in macrophage and dendritic cell phagosomes leads to activation of the NLRP3 inflammasome, a cytosolic complex that regulates processing and secretion of interleukin (IL)-1 beta and IL-18. While many inflammatory responses to peptidoglycan are mediated by detection of its muramyl dipeptide component in the cytosol by NOD2, we report here that NLRP3 inflammasome activation is caused by release of N-acetylglucosamine that is detected in the cytosol by the glycolytic enzyme hexokinase. Inhibition of hexokinase by N-acetylglucosamine causes its dissociation from mitochondria outer membranes, and we found that this is sufficient to activate the NLRP3 inflammasome. In addition, we observed that glycolytic inhibitors and metabolic conditions affecting hexokinase function and localization induce inflammasome activation. While previous studies have demonstrated that signaling by pattern recognition receptors can regulate metabolic processes, this study shows that a metabolic enzyme can act as a pattern recognition receptor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available